Stocktoria
ALNYLAM PHARMACEUTICALS, INC. ALNY
ALNYLAM PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,547,663 | $2.3B | 7.09% |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | $659.3M | 1.48% |
| DODGE & COX | 1,929,253 | $638.3M | 1.43% |
| D. E. Shaw & Co., Inc. | 1,474,362 | $487.8M | 1.09% |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | $297.9M | 0.68% |
| MILLENNIUM MANAGEMENT LLC | 493,087 | $163.1M | 0.37% |
| CITADEL ADVISORS LLC | 111,215 | $36.8M | 0.08% |
| Bridgewater Associates, LP | 106,592 | $35.3M | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.